Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
PaperCitations, authors & open-access status
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 819 citations, 2021 year and bronze oa status.
819
Citations
2021
Year
bronze
OA Status